Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shatin

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Pediatrics|October 2, 1998
Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed careD Shatin, R Levin, H T Ireys, et al.
The American Journal of Managed Care|August 29, 1998
Role of technology assessment in health benefits coverage for medical devicesN M Braslow, D Shatin, D B McCarthy, et al.
JAMA|August 22, 2001
Liver enzyme monitoring in patients treated with troglitazoneD J Graham, C R Drinkard, D Shatin, et al.
Health Services Research|April 13, 1999
Medical records and privacy: empirical effects of legislationD B McCarthy, D Shatin, C R Drinkard, et al.
Stereotactic and Functional Neurosurgery|January 1, 1995
Epidural spinal cord stimulation in the management of spasms in spinal cord injury: a prospective studyG Barolat, K Singh-Sahni, W E Staas, et al.
The American Journal of Managed Care|April 20, 2001
Healthy pregnancy program in a national managed care organization: evaluation of satisfaction and health behavior outcomesC R Drinkard, D Shatin, D Luo, et al.
Pharmacotherapy|December 29, 2000
Tramadol and seizures: a surveillance study in a managed care populationJ S Gardner, D Blough, C R Drinkard, et al.
Neurosurgery|June 1, 1995
Prognostic factors of spinal cord stimulation for chronic back and leg painK J Burchiel, V C Anderson, B J Wilson, et al.
BMJ (Clinical Research Ed.)|October 27, 2001
Mobility impairments and use of preventive services in women with multiple sclerosis: observational studyE Cheng, L Myers, S Wolf, et al.
Arthritis and Rheumatism|March 3, 2007
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugsJ R Curtis, C Martin, K G Saag, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Pediatrics|October 2, 1998
Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed careD Shatin, R Levin, H T Ireys, et al.
The American Journal of Managed Care|August 29, 1998
Role of technology assessment in health benefits coverage for medical devicesN M Braslow, D Shatin, D B McCarthy, et al.
JAMA|August 22, 2001
Liver enzyme monitoring in patients treated with troglitazoneD J Graham, C R Drinkard, D Shatin, et al.
Health Services Research|April 13, 1999
Medical records and privacy: empirical effects of legislationD B McCarthy, D Shatin, C R Drinkard, et al.
Stereotactic and Functional Neurosurgery|January 1, 1995
Epidural spinal cord stimulation in the management of spasms in spinal cord injury: a prospective studyG Barolat, K Singh-Sahni, W E Staas, et al.
The American Journal of Managed Care|April 20, 2001
Healthy pregnancy program in a national managed care organization: evaluation of satisfaction and health behavior outcomesC R Drinkard, D Shatin, D Luo, et al.
Pharmacotherapy|December 29, 2000
Tramadol and seizures: a surveillance study in a managed care populationJ S Gardner, D Blough, C R Drinkard, et al.
Neurosurgery|June 1, 1995
Prognostic factors of spinal cord stimulation for chronic back and leg painK J Burchiel, V C Anderson, B J Wilson, et al.
BMJ (Clinical Research Ed.)|October 27, 2001
Mobility impairments and use of preventive services in women with multiple sclerosis: observational studyE Cheng, L Myers, S Wolf, et al.
Arthritis and Rheumatism|March 3, 2007
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugsJ R Curtis, C Martin, K G Saag, et al.
Pageof 3